Paediatric guidance

Knowledge * Excellence * Guidelines * Paediatric guidance

BSPAR logo

These guidance notes have been produced by the British Society for Paediatric and Adolescent Rheumatology and other organisations to provide support to those working in paediatric and adolescent care. Other documents are currently under review and will be published shortly.



British Society for Paediatric and Adolescent Rheumatology guidance:

British Society for Paediatric and Adolescent Rheumatology / ARMA standards of care for JIA

These Standards of Care are designed to help and support children and young people with JIA and their families and all professional teams, by providing a statement of the minimum standards of care required by such children and young people.

Find out more >

RCN guidelines:

Administering subcutaneous methotrexate for inflammatory arthritis

This is the third edition of the RCN’s guidance and has been updated to ensure the publication contains the latest evidence-based guidance to support practitioners in the safe and confident administration of subcutaneous methotrexate in a variety of primary and secondary care settings, including community and managed care environments. The guidance covers aspects of both adult and children/young people’s care.

Find out more >

Adolescent transitional care document

This guidance aims to help achieve a seamless transfer using a national clinical pathway framework and is divided into two parts – the first provides an overview of the issues to consider when planning transition services, and the second provides a practical framework for working with young people at each of the major phases of adolescence.

Find out more >

Assessing, managing and monitoring biologic therapies for inflammatory arthritis

This updated guidance is for rheumatology specialist practitioners and the wider health care team on assessing, managing and monitoring biologic therapies for inflammatory arthritis.

Find out more >

PRes and SHARE guidelines:

PReS (Paediatric Rheumatology European Association) and SHARE (Single Hub and Access point for paediatric Rheumatology in Europe) have produced a number of recommendations on the management and treatment of conditions for paediatric and adolescent care.

View below the following recommendations:

Antiphospholipid syndrome

Find out more >

Autoinflammatory diseases

Find out more >


Find out more >

Transitional care

Find out more >